Literature DB >> 1889042

Human infections associated with Bordetella bronchiseptica.

B F Woolfrey1, J A Moody.   

Abstract

This study examines the potential of Bordetella bronchiseptica to act as a human pathogen. After encountering two patients from whom B. bronchiseptica was isolated, we searched the literature and found 23 reports in which a human infection was reported in association with B. bronchiseptica. As a basis for evaluating these cases, we summarize the literature about the current microbiological status of B. bronchiseptica, the pathology and pathogenic mechanisms associated with the microorganism, and the likelihood of it acting as a commensal or colonizer. From this review we conclude that B. bronchiseptica has been rarely isolated from humans despite their considerable exposure to animal sources. Evidence suggests that B. bronchiseptica may be rarely encountered as a commensal or colonizer of the respiratory tract of humans and rarely in association with infection. When found as a probable pathogen, most infections have been respiratory tract in origin and have occurred in severely compromised hosts.

Entities:  

Mesh:

Year:  1991        PMID: 1889042      PMCID: PMC358197          DOI: 10.1128/CMR.4.3.243

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  112 in total

1.  Pertussis. A reappraisal and report of 190 confirmed cases.

Authors:  F Brooksaler; J D Nelson
Journal:  Am J Dis Child       Date:  1967-10

2.  Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates.

Authors:  J E Mortensen; A Brumbach; T R Shryock
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

3.  Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin-producing ability.

Authors:  H Nagano; T Nakai; Y Horiguchi; K Kume
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

4.  Nonfermentative bacilli associated with man. I. Nomenclature.

Authors:  M J Pickett; C R Manclark
Journal:  Am J Clin Pathol       Date:  1970-08       Impact factor: 2.493

5.  Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.

Authors:  T A Kurzynski; D M Boehm; J A Rott-Petri; R F Schell; P E Allison
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

6.  Development of turbinate lesions and nasal colonization by Bordetella bronchiseptica and Pasteurella multocida during long-term exposure of healthy pigs to pigs affected by atrophic rhinitis.

Authors:  L R Bäckström; T A Brim; M T Collins
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

7.  Bacteriological variation among Bordetella bronchiseptica isolates from dogs and other species.

Authors:  D A Bemis; H A Greisen; M J Appel
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

8.  Pasteurella multocida and Bordetella bronchiseptica in atrophic rhinitis and pneumonia in swine.

Authors:  R P Cowart; L Bäckström; T A Brim
Journal:  Can J Vet Res       Date:  1989-07       Impact factor: 1.310

9.  [Measures to be adopted in the prevention and treatment of atrophic rhinitis in piglets under field conditions (author's transl)].

Authors:  Z Bercovich; M F De Jong
Journal:  Tijdschr Diergeneeskd       Date:  1977-04-01

10.  Vaccination with Bordetella bronchiseptica vaccine on a farm with atrophic rhinitis: an evaluation of a field experiment.

Authors:  Z Bercovich; R A Oosterwoud
Journal:  Tijdschr Diergeneeskd       Date:  1977-04-15
View more
  84 in total

1.  Restriction endonuclease analysis discriminates Bordetella bronchiseptica isolates.

Authors:  R E Sacco; K B Register; G E Nordholm
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence.

Authors:  N P West; H Jungnitz; J T Fitter; J D McArthur; C A Guzmán; M J Walker
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation.

Authors:  Frédéric Wallet; Thierry Perez; Sylvie Armand; Benoit Wallaert; René J Courcol
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Application of 16S rRNA gene sequencing to identify Bordetella hinzii as the causative agent of fatal septicemia.

Authors:  M M Kattar; J F Chavez; A P Limaye; S L Rassoulian-Barrett; S L Yarfitz; L C Carlson; Y Houze; S Swanzy; B L Wood; B T Cookson
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract.

Authors:  Pascale Gueirard; Patrick Ave; Anne-Marie Balazuc; Sabine Thiberge; Michel Huerre; Genevieve Milon; Nicole Guiso
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 6.  Towards improved accuracy of Bordetella pertussis nucleic acid amplification tests.

Authors:  Michael Loeffelholz
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

7.  Food provisioning alters infection dynamics in populations of a wild rodent.

Authors:  Kristian M Forbes; Heikki Henttonen; Varpu Hirvelä-Koski; Anja Kipar; Tapio Mappes; Peter Stuart; Otso Huitu
Journal:  Proc Biol Sci       Date:  2015-10-07       Impact factor: 5.349

8.  Expression of BfrH, a putative siderophore receptor of Bordetella bronchiseptica, is regulated by iron, Fur1, and the extracellular function sigma factor EcfI.

Authors:  Jonathan M Burgos; Natalie D King-Lyons; Terry D Connell
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

9.  bvg Repression of alcaligin synthesis in Bordetella bronchiseptica is associated with phylogenetic lineage.

Authors:  P C Giardina; L A Foster; J M Musser; B J Akerley; J F Miller; D W Dyer
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

10.  Immunomagnetic separation and solid-phase detection of Bordetella pertussis.

Authors:  M Stark; E Reizenstein; M Uhlén; J Lundeberg
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.